Gara Jalqabaatti › Sindroomii Bronchiolitis Obliterans › North Carolina
Qorannoo klinikaalii Sindroomii Bronchiolitis Obliterans North Carolina keessatti
Qorannoo 7 Sindroomii Bronchiolitis Obliterans f North Carolina keessatti hirmaatuu jiru.
Magaalota North Carolina keessatti
Takkalaa qorannoo (Ingiliffa)
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Duke Eye Center - Ophthalmology, Durham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 65 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07395232A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Levine Cancer Institute, Charlotte
- Duke Cancer Center, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Wake Forest Baptist Medical Center, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05919511A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of North Carolina At Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06615050Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Duke, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT06233110A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Levine Cancer Institute, Charlotte
- Duke University Hospital, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT06619561Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.